ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 351 filers reported holding ENCOMPASS HEALTH CORP in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $319,000 | -6.2% | 4,251 | -2.6% | 0.03% | +3.2% |
| Q2 2021 | $340,000 | -10.8% | 4,363 | -2.8% | 0.03% | -8.8% |
| Q1 2021 | $381,000 | -2.6% | 4,489 | -5.1% | 0.03% | -8.1% |
| Q4 2020 | $391,000 | +21.1% | 4,729 | -4.9% | 0.04% | +8.8% |
| Q3 2020 | $323,000 | +2.2% | 4,973 | -2.7% | 0.03% | -2.9% |
| Q2 2020 | $316,000 | -3.4% | 5,109 | +0.1% | 0.04% | +20.7% |
| Q1 2020 | $327,000 | -17.2% | 5,102 | -10.5% | 0.03% | +61.1% |
| Q4 2019 | $395,000 | +1.8% | 5,698 | -7.0% | 0.02% | -5.3% |
| Q3 2019 | $388,000 | +3.5% | 6,129 | +3.7% | 0.02% | +5.6% |
| Q2 2019 | $375,000 | +0.3% | 5,913 | -7.7% | 0.02% | -5.3% |
| Q1 2019 | $374,000 | +8.1% | 6,406 | +14.4% | 0.02% | -9.5% |
| Q4 2018 | $346,000 | -24.8% | 5,602 | -5.1% | 0.02% | -4.5% |
| Q3 2018 | $460,000 | +15.9% | 5,902 | +0.6% | 0.02% | +15.8% |
| Q2 2018 | $397,000 | +38.3% | 5,865 | +16.7% | 0.02% | +46.2% |
| Q1 2018 | $287,000 | – | 5,025 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |